Cimmino et al. documented a tumor-suppressor role of TET1 and found alternative mechanisms of TET1 inactivation in human B-cell non-Hodgkin lymphomas (NHL) [33]. This evidence concerns the gene TET1 and non-Hodgkin lymphoma.